# data[].attributes.body.value
Bill Bigelow started his tenure at OTT as a Docketing Manager in February 2013 after graduating from the University of Maryland, College Park. In that role he began supporting the NIH TechTracS system and helped to launch the NIH Law Firm Portal, which he continues to support today. In January 2018, Bill joined Sapient as a Business Analyst on the ETT Team, becoming an expert on the NIH technology transfer business process and gathering requirements in order to implement the new ETT system. In April 2021 Bill rejoined OTT in his current position as an IT Specialist where he serves as the Development Manager of the ETT system.

# data[].attributes.body.processed
Bill Bigelow started his tenure at OTT as a Docketing Manager in February 2013 after graduating from the University of Maryland, College Park. In that role he began supporting the NIH TechTracS system and helped to launch the NIH Law Firm Portal, which he continues to support today. In January 2018, Bill joined Sapient as a Business Analyst on the ETT Team, becoming an expert on the NIH technology transfer business process and gathering requirements in order to implement the new ETT system. In April 2021 Bill rejoined OTT in his current position as an IT Specialist where he serves as the Development Manager of the ETT system.

# data[].attributes.body.value
Sue joined OTT in 2002 as a technology licensing specialist, following post-doctoral positions at the U.S. Food and Drug Administration and Purdue University, focusing on characterization of biomolecules by NMR spectroscopy. Sue received her Ph.D. from the Department of Chemistry, Emory University, and her B.S. from the Department of Chemistry, University of Delaware. These research efforts resulted in several peer-reviewed journal publications as well as book chapters.

# data[].attributes.body.processed
Sue joined OTT in 2002 as a technology licensing specialist, following post-doctoral positions at the U.S. Food and Drug Administration and Purdue University, focusing on characterization of biomolecules by NMR spectroscopy. Sue received her Ph.D. from the Department of Chemistry, Emory University, and her B.S. from the Department of Chemistry, University of Delaware. These research efforts resulted in several peer-reviewed journal publications as well as book chapters.

# data[].attributes.body.value
Dr. Campbell began his career with the U.S. Patent and Trademark Office, where he first worked as a patent examiner for four years and was subsequently promoted to a primary patent examiner, a position in which he served for five years. During his tenure there, Dr. Campbell allowed over 400 patents, specializing in a variety of physiological conditions used for nucleic acid detection via hybridization, nucleic acid amplification (PCR), detection of tumors/cancer via mutations, recombinant polypeptides, human genes, and bioinformatics. Dr. Campbell has extensive law firm experience preparing and prosecuting patent applications in a wide variety of biotechnology areas. He holds a Ph.D. in biochemistry from Albert Einstein College of Medicine, supplemented with post-doctoral training at the National Institute of Allergy and Infectious Diseases (NIAID). He is a patent agent registered to practice before the U.S. Patent and Trademark Office.

# data[].attributes.body.processed
Dr. Campbell began his career with the U.S. Patent and Trademark Office, where he first worked as a patent examiner for four years and was subsequently promoted to a primary patent examiner, a position in which he served for five years. During his tenure there, Dr. Campbell allowed over 400 patents, specializing in a variety of physiological conditions used for nucleic acid detection via hybridization, nucleic acid amplification (PCR), detection of tumors/cancer via mutations, recombinant polypeptides, human genes, and bioinformatics. Dr. Campbell has extensive law firm experience preparing and prosecuting patent applications in a wide variety of biotechnology areas. He holds a Ph.D. in biochemistry from Albert Einstein College of Medicine, supplemented with post-doctoral training at the National Institute of Allergy and Infectious Diseases (NIAID). He is a patent agent registered to practice before the U.S. Patent and Trademark Office.

# data[].attributes.body.value
Dr. Chang joined OTT in May 2008. Prior to joining OTT, he was a technology transfer specialist fellow at the National Cancer Institute (NCI) Technology Transfer Center assisting NCI scientists with agreements for the transfer of materials and collaborations with public and private entities. This followed several years as a postdoctoral fellow at NCI Frederick where he studied and published several papers on retroviral vectors and replication. Dr. Chang received his Ph.D. in Microbiology and Immunology from Louisiana State University Health Sciences Center and his dissertation focused on research examining membrane fusion mediated by the spike glycoprotein of coronaviruses. He received a B.S. degree in Physiology and Neurobiology from the University of Maryland.

# data[].attributes.body.processed
Dr. Chang joined OTT in May 2008. Prior to joining OTT, he was a technology transfer specialist fellow at the National Cancer Institute (NCI) Technology Transfer Center assisting NCI scientists with agreements for the transfer of materials and collaborations with public and private entities. This followed several years as a postdoctoral fellow at NCI Frederick where he studied and published several papers on retroviral vectors and replication. Dr. Chang received his Ph.D. in Microbiology and Immunology from Louisiana State University Health Sciences Center and his dissertation focused on research examining membrane fusion mediated by the spike glycoprotein of coronaviruses. He received a B.S. degree in Physiology and Neurobiology from the University of Maryland.

# data[].attributes.body.value
Dr. Sabarni Chatterjee recently re-joined OTT as the Deputy Director. Sabarni comes to OTT from NIAID’s Technology Transfer and Intellectual Property Office where he served as the Branch Chief of Branch B supervising technology transfer matters for NIAID’s intramural and extramural programs including the Vaccine Research Center and the Division of Clinical Research. Prior to that, Sabarni was in NCI’s Technology Transfer Center, where he served as a Unit Supervisor from 2019-2022 and a Sr. Technology Transfer Manager from 2015-2019. Sabarni started his NIH technology transfer career at OTT where he was a Licensing and Patenting Manager in the Cancer Branch. Sabarni has a diverse and extensive technology transfer background; he has worked in industry, patent law, and in multiple NIH tech transfer offices. Prior to coming to NIH, Sabarni conducted postdoctoral training in cancer biology at Harvard Medical School. Sabarni’s educational credentials include an M.B.A. from the Isenberg School of Business, University of Massachusetts at Amherst, and a Ph.D. in Biological Chemistry from the State University of New York at Binghamton, where he conducted research in the field of structure-activity relationships of novel anti-cancer compounds. Throughout, he has dedicated time in multiple areas benefitting the NIH TT community, including trans-NIH working groups, Federal Laboratory Consortium projects, serving as a faculty member at the FAES University, and more. He has also enjoyed mentoring junior colleagues and others seeking to learn more about technology transfer.

# data[].attributes.body.processed
Dr. Sabarni Chatterjee recently re-joined OTT as the Deputy Director. Sabarni comes to OTT from NIAID’s Technology Transfer and Intellectual Property Office where he served as the Branch Chief of Branch B supervising technology transfer matters for NIAID’s intramural and extramural programs including the Vaccine Research Center and the Division of Clinical Research. Prior to that, Sabarni was in NCI’s Technology Transfer Center, where he served as a Unit Supervisor from 2019-2022 and a Sr. Technology Transfer Manager from 2015-2019. Sabarni started his NIH technology transfer career at OTT where he was a Licensing and Patenting Manager in the Cancer Branch. Sabarni has a diverse and extensive technology transfer background; he has worked in industry, patent law, and in multiple NIH tech transfer offices. Prior to coming to NIH, Sabarni conducted postdoctoral training in cancer biology at Harvard Medical School. Sabarni’s educational credentials include an M.B.A. from the Isenberg School of Business, University of Massachusetts at Amherst, and a Ph.D. in Biological Chemistry from the State University of New York at Binghamton, where he conducted research in the field of structure-activity relationships of novel anti-cancer compounds. Throughout, he has dedicated time in multiple areas benefitting the NIH TT community, including trans-NIH working groups, Federal Laboratory Consortium projects, serving as a faculty member at the FAES University, and more. He has also enjoyed mentoring junior colleagues and others seeking to learn more about technology transfer.

# data[].attributes.body.value
Kevin has worked at the NIH in the Office of Technology Transfer (OTT) since 2016.

# data[].attributes.body.processed
Kevin has worked at the NIH in the Office of Technology Transfer (OTT) since 2016.

# data[].attributes.body.value
Kyle Doss has been a Program (Patent) Analyst at the Office of Technology Transfer (OTT) since 2021. Previously, he was a contractor for the Technology Transfer Portfolio Management Unit (TTPMU) in the Office of Technology Transfer specializing in Patent Docketing from 2015 to 2021. Mr. Doss now serves as the subject matter expert on Patent records in the Enterprise Technology Transfer (ETT) system. Mr. Doss received a B.A. degree in Environmental Studies from Salisbury University in 2015.

# data[].attributes.body.processed
Kyle Doss has been a Program (Patent) Analyst at the Office of Technology Transfer (OTT) since 2021. Previously, he was a contractor for the Technology Transfer Portfolio Management Unit (TTPMU) in the Office of Technology Transfer specializing in Patent Docketing from 2015 to 2021. Mr. Doss now serves as the subject matter expert on Patent records in the Enterprise Technology Transfer (ETT) system. Mr. Doss received a B.A. degree in Environmental Studies from Salisbury University in 2015.

# data[].attributes.body.value
Steven M. Ferguson currently serves as the Deputy Director, Licensing and Entrepreneurship. Prior to joining NIH Office of Technology Transfer in 1990, Mr. Ferguson served in marketing and management positions in biomedical firms subsequent to being a scientist at the National Cancer Institute. His healthcare experience has also included work as Director of Marketing and Public Relations for a rural 70-bed hospital. Registered to practice before the USPTO and a Certified Licensing Professional (CLP), Mr. Ferguson also holds Master's Degrees in Business Administration (George Washington University) and Chemistry (University of Cincinnati) as well as Bachelor’s Degree in Chemistry (Case Western Reserve University). Mr. Ferguson has been an economic reviewer for Maryland Industrial Partnerships (MIPS) as well as the Advanced Technology Program (ATP) grant programs and is an instructor for both the USDA Graduate School and the NIH FAES Graduate School where he is also the department chair for the new Certificate in Technology Transfer Program. Mr. Ferguson was also the Susan T. and Charles E. Harris Visiting Lecturer at the Watson School of Biological Sciences at the Cold Spring Harbor Laboratory and has published articles on licensing and technology transfer issues.

# data[].attributes.body.processed
Steven M. Ferguson currently serves as the Deputy Director, Licensing and Entrepreneurship. Prior to joining NIH Office of Technology Transfer in 1990, Mr. Ferguson served in marketing and management positions in biomedical firms subsequent to being a scientist at the National Cancer Institute. His healthcare experience has also included work as Director of Marketing and Public Relations for a rural 70-bed hospital. Registered to practice before the USPTO and a Certified Licensing Professional (CLP), Mr. Ferguson also holds Master's Degrees in Business Administration (George Washington University) and Chemistry (University of Cincinnati) as well as Bachelor’s Degree in Chemistry (Case Western Reserve University). Mr. Ferguson has been an economic reviewer for Maryland Industrial Partnerships (MIPS) as well as the Advanced Technology Program (ATP) grant programs and is an instructor for both the USDA Graduate School and the NIH FAES Graduate School where he is also the department chair for the new Certificate in Technology Transfer Program. Mr. Ferguson was also the Susan T. and Charles E. Harris Visiting Lecturer at the Watson School of Biological Sciences at the Cold Spring Harbor Laboratory and has published articles on licensing and technology transfer issues.

# data[].attributes.body.value
Debra Flint joined NIH OTT in July 2016 as a Monitoring & Enforcement Officer, and from September 2019 – January 2020, served as the Supervisory Technology Monitoring & Enforcement Specialist. Prior to joining NIH OTT, Debra worked for 6 years as the IP Manager for The Henry M. Jackson Foundation in the OTT office. Debra received a B.S. in molecular biology with a minor in chemistry from the Salisbury University, a M.S. in Biotechnology, with concentrations in Regulatory Affairs and Biotech Enterprise, from Johns Hopkins University, and her patent agent certification in 2007.

# data[].attributes.body.processed
Debra Flint joined NIH OTT in July 2016 as a Monitoring & Enforcement Officer, and from September 2019 – January 2020, served as the Supervisory Technology Monitoring & Enforcement Specialist. Prior to joining NIH OTT, Debra worked for 6 years as the IP Manager for The Henry M. Jackson Foundation in the OTT office. Debra received a B.S. in molecular biology with a minor in chemistry from the Salisbury University, a M.S. in Biotechnology, with concentrations in Regulatory Affairs and Biotech Enterprise, from Johns Hopkins University, and her patent agent certification in 2007.

# data[].attributes.field_job_title
Technology Transfer & Patenting Specialist (NCATS)

# data[].attributes.body.value
Jaime is a USPTO alum where she worked in Art Unit 1634 evaluating nucleic acid hybridization-related patent applications. Prior to working at the PTO, she worked at a small systems biology startup company in Cambridge, MA. Jaime obtained her master’s degree from the University of Heidelberg in Heidelberg, Germany and her bachelor’s degree from the George Washington University in Washington, DC.

# data[].attributes.body.processed
Jaime is a USPTO alum where she worked in Art Unit 1634 evaluating nucleic acid hybridization-related patent applications. Prior to working at the PTO, she worked at a small systems biology startup company in Cambridge, MA. Jaime obtained her master’s degree from the University of Heidelberg in Heidelberg, Germany and her bachelor’s degree from the George Washington University in Washington, DC.

# data[].attributes.body.value
Simmone Henry joined the NIH community in 2005, initially serving on the administrative staff for the Director of the National Cancer Institute (NCI). She then transitioned to the role of Program Specialist at the NCI Office of Technology Transfer Center, where she provided pivotal support to the License Patent Managers. In January 2017, Simmone embarked on a new chapter as a member of the Royalties Administration Unit (RAU) within the NIH Office of Technology Transfer (OTT). Holding a Bachelor's Degree in Communication and an MBA, Simmone brings a wealth of knowledge and expertise to her role. As a Royalties Coordinator, she is integral in administratively and technically coordinating the NIH royalties program, as well as managing the reimbursement of patent prosecution costs from licensees. Her extensive experience and educational background enhances her commitment to excellence in advancing the NIH's mission.

# data[].attributes.body.processed
Simmone Henry joined the NIH community in 2005, initially serving on the administrative staff for the Director of the National Cancer Institute (NCI). She then transitioned to the role of Program Specialist at the NCI Office of Technology Transfer Center, where she provided pivotal support to the License Patent Managers. In January 2017, Simmone embarked on a new chapter as a member of the Royalties Administration Unit (RAU) within the NIH Office of Technology Transfer (OTT). Holding a Bachelor's Degree in Communication and an MBA, Simmone brings a wealth of knowledge and expertise to her role. As a Royalties Coordinator, she is integral in administratively and technically coordinating the NIH royalties program, as well as managing the reimbursement of patent prosecution costs from licensees. Her extensive experience and educational background enhances her commitment to excellence in advancing the NIH's mission.

# data[].attributes.body.value
Richelle Holnick has served as the Marketing Specialist for the Office of Technology Transfer (OTT) as a contractor since 2020. She focuses on marketing available NIH technologies and increasing partnership and engagement. Ms. Holnick received her BS in Business Administration: Marketing from the University of Mary Washington and is currently pursuing a Master's degree in Integrated Marketing Communications from Georgetown University.

# data[].attributes.body.processed
Richelle Holnick has served as the Marketing Specialist for the Office of Technology Transfer (OTT) as a contractor since 2020. She focuses on marketing available NIH technologies and increasing partnership and engagement. Ms. Holnick received her BS in Business Administration: Marketing from the University of Mary Washington and is currently pursuing a Master's degree in Integrated Marketing Communications from Georgetown University.

# data[].attributes.body.value
Tara Kirby has been the Director of the Office of Technology Transfer (OTT) since 2020.  Previously, she supervised the CDC Team at the NIAID Technology Transfer and Intellectual Property Office from 2015 to 2020. Dr. Kirby also worked at OTT from 2006 to 2015, starting as a postdoctoral fellow and ultimately assuming the role of CDC unit chief. Her research experience includes postdoctoral research at the National Institute of Diabetes and Digestive and Kidney Diseases investigating Y. pestis membrane protein structure, as well as pre-doctoral and postdoctoral research at the University of Minnesota focused on structure/function relationships of cardiac membrane proteins.  Dr. Kirby received a B.S. degree in Chemistry from the California Institute of Technology and a Ph.D. degree in Biochemistry, Molecular Biology, and Biophysics from the University of Minnesota.

# data[].attributes.body.processed
Tara Kirby has been the Director of the Office of Technology Transfer (OTT) since 2020.  Previously, she supervised the CDC Team at the NIAID Technology Transfer and Intellectual Property Office from 2015 to 2020. Dr. Kirby also worked at OTT from 2006 to 2015, starting as a postdoctoral fellow and ultimately assuming the role of CDC unit chief. Her research experience includes postdoctoral research at the National Institute of Diabetes and Digestive and Kidney Diseases investigating Y. pestis membrane protein structure, as well as pre-doctoral and postdoctoral research at the University of Minnesota focused on structure/function relationships of cardiac membrane proteins.  Dr. Kirby received a B.S. degree in Chemistry from the California Institute of Technology and a Ph.D. degree in Biochemistry, Molecular Biology, and Biophysics from the University of Minnesota.

# data[].attributes.body.value
Dr. Lambertson joined the OTT in 2005. Prior to joining the NIH, Dr. Lambertson was a patent examiner with the US Patent and Trademark Office. Dr. Lambertson received his Ph.D. in Biochemistry and Molecular Biology from The University of Medicine and Dentistry of New Jersey, and his BS in Biochemistry from Rutgers University, where he was a George H. Cook Scholar.

# data[].attributes.body.processed
Dr. Lambertson joined the OTT in 2005. Prior to joining the NIH, Dr. Lambertson was a patent examiner with the US Patent and Trademark Office. Dr. Lambertson received his Ph.D. in Biochemistry and Molecular Biology from The University of Medicine and Dentistry of New Jersey, and his BS in Biochemistry from Rutgers University, where he was a George H. Cook Scholar.

# data[].attributes.body.value
Laura Lane-Unsworth has served as the Annuities Administrator for the Office of Technology Transfer (OTT) since 2020. She also serves as the Records Management Liaison / Document Retention Officer for OTT and has worked at OTT since 1995. Mrs. Lane-Unsworth currently maintains a COR Level III certification and she holds a Bachelor of Arts degree from Longwood University.

# data[].attributes.body.processed
Laura Lane-Unsworth has served as the Annuities Administrator for the Office of Technology Transfer (OTT) since 2020. She also serves as the Records Management Liaison / Document Retention Officer for OTT and has worked at OTT since 1995. Mrs. Lane-Unsworth currently maintains a COR Level III certification and she holds a Bachelor of Arts degree from Longwood University.

# data[].attributes.body.value
Tim Leahy has been the Chief of the Technology Transfer Portfolio Management Unit in the Office of Technology Transfer (OTT) since 2016. Previously, he served as the Associate Director of the Program Management Office (PMO) at NIH/OER/eRA from 2007 to 2015. Mr. Leahy has held a variety of management and senior technical positions in the field of Information Technology, Quality Assurance and Program/Project Management over the past 30+ years. He specializes in IT application development and is an expert in all aspects of the Software Development Lifecycle (SDLC), particularly the Enterprise Performance Life Cycle (EPLC) framework used at HHS. Mr. Leahy’s past certifications include MCSA and Lotus Notes Developer. He has also been an ISO 9000 certified auditor and is an IV&V expert. Mr. Leahy currently maintains a PMP certification, as well as a COR Level II and a FAC P/PM Level III. He holds a Bachelor of Science degree from Towson University.

# data[].attributes.body.processed
Tim Leahy has been the Chief of the Technology Transfer Portfolio Management Unit in the Office of Technology Transfer (OTT) since 2016. Previously, he served as the Associate Director of the Program Management Office (PMO) at NIH/OER/eRA from 2007 to 2015. Mr. Leahy has held a variety of management and senior technical positions in the field of Information Technology, Quality Assurance and Program/Project Management over the past 30+ years. He specializes in IT application development and is an expert in all aspects of the Software Development Lifecycle (SDLC), particularly the Enterprise Performance Life Cycle (EPLC) framework used at HHS. Mr. Leahy’s past certifications include MCSA and Lotus Notes Developer. He has also been an ISO 9000 certified auditor and is an IV&V expert. Mr. Leahy currently maintains a PMP certification, as well as a COR Level II and a FAC P/PM Level III. He holds a Bachelor of Science degree from Towson University.

# data[].attributes.body.value
Commander, United States Public Health Service (USPHS)

Charlene graduated with a B.S. in Chemistry with a Specialization in Biochemistry from the University of Virginia and completed her Ph.D. in Biochemistry and Molecular Biology at Howard University.

# data[].attributes.body.processed
Commander, United States Public Health Service (USPHS)

Charlene graduated with a B.S. in Chemistry with a Specialization in Biochemistry from the University of Virginia and completed her Ph.D. in Biochemistry and Molecular Biology at Howard University.

# data[].attributes.body.value
Dr. McCue joined OTT in June 2009. Prior to joining OTT, Dr. McCue was a technology transfer fellow at the National Cancer Institute (NCI)’s Technology Transfer Center. Dr. McCue completed research fellowships at the NCI-Frederick, at the National Center for Complementary and Alternative Medicine (NCCAM), and at the Genome Research Facility of the National Aeronautics and Space Administration (NASA). Registered to practice before the U.S. Patent and Trademark Office, Dr. McCue holds a Doctor of Philosophy degree in Molecular and Cellular Biology, a Master of Science degree in Biochemistry, and a Bachelor of Science degree with Honors in Biochemistry and Molecular Biology, all from the University of Massachusetts Amherst. He has authored or co-authored over 30 scientific articles and book chapters.

# data[].attributes.body.processed
Dr. McCue joined OTT in June 2009. Prior to joining OTT, Dr. McCue was a technology transfer fellow at the National Cancer Institute (NCI)’s Technology Transfer Center. Dr. McCue completed research fellowships at the NCI-Frederick, at the National Center for Complementary and Alternative Medicine (NCCAM), and at the Genome Research Facility of the National Aeronautics and Space Administration (NASA). Registered to practice before the U.S. Patent and Trademark Office, Dr. McCue holds a Doctor of Philosophy degree in Molecular and Cellular Biology, a Master of Science degree in Biochemistry, and a Bachelor of Science degree with Honors in Biochemistry and Molecular Biology, all from the University of Massachusetts Amherst. He has authored or co-authored over 30 scientific articles and book chapters.

# data[].attributes.field_job_title
Sr Licensing & Patenting Manager (NIAID)

# data[].attributes.body.value
Prior to joining the NIH, Dr. Mitzelfelt was a technology analyst in the Office of Technology Commercialization at the University of Maryland, College Park. Before starting his career in technology transfer he was a postdoc and intern in the technology transfer office at Emory University. Dr. Mitzelfelt obtained a Ph.D. in Medical Science with an advanced concentration in Neuroscience from the University of Florida where he studied the interplay of aging, chronic pain, and chronic opioid administration. He also received a B.S. degree in Honors in Neuroscience from Regis University in Denver, Colorado.

# data[].attributes.body.processed
Prior to joining the NIH, Dr. Mitzelfelt was a technology analyst in the Office of Technology Commercialization at the University of Maryland, College Park. Before starting his career in technology transfer he was a postdoc and intern in the technology transfer office at Emory University. Dr. Mitzelfelt obtained a Ph.D. in Medical Science with an advanced concentration in Neuroscience from the University of Florida where he studied the interplay of aging, chronic pain, and chronic opioid administration. He also received a B.S. degree in Honors in Neuroscience from Regis University in Denver, Colorado.

# data[].attributes.field_job_title
CDC Team Licensing and Patenting Manager (NIAID)

# data[].attributes.body.value
Melborne Moon has been with the Office of Technology Transfer (OTT) since 2006 and has served as a Royalties Analyst since August 2022.

# data[].attributes.body.processed
Melborne Moon has been with the Office of Technology Transfer (OTT) since 2006 and has served as a Royalties Analyst since August 2022.

# data[].attributes.body.value
Dr. Reichman joined the OTT in December 1999. Prior to joining the NIH, Dr. Reichman worked for twenty years (1980-1999) in the biotechnology industry, specializing in the field of medical diagnostics. From 1973 to 1980, Dr. Reichman conducted academic research at Sloan Kettering Institute for Cancer Research in New York. Dr. Reichman is an author of 26 scientific papers and an inventor on several patents. Dr. Reichman received his Ph.D. in Medicinal Chemistry from the Hebrew University in Jerusalem, Israel, and obtained an M.B.A. degree from Iona College in New York.

# data[].attributes.body.processed
Dr. Reichman joined the OTT in December 1999. Prior to joining the NIH, Dr. Reichman worked for twenty years (1980-1999) in the biotechnology industry, specializing in the field of medical diagnostics. From 1973 to 1980, Dr. Reichman conducted academic research at Sloan Kettering Institute for Cancer Research in New York. Dr. Reichman is an author of 26 scientific papers and an inventor on several patents. Dr. Reichman received his Ph.D. in Medicinal Chemistry from the Hebrew University in Jerusalem, Israel, and obtained an M.B.A. degree from Iona College in New York.

# data[].attributes.body.value
Lauren Rhoads currently serves as a Royalties Coordinator. Prior to joining NIH Office of Technology Transfer in 2021, Lauren served as an Accounting Technician with the NIH Office of Financial Management. She previously served at the Veterans Health Administration and a veteran’s non-profit. In 2021, she received an Honor Award from the NIH Office of the Director.

# data[].attributes.body.processed
Lauren Rhoads currently serves as a Royalties Coordinator. Prior to joining NIH Office of Technology Transfer in 2021, Lauren served as an Accounting Technician with the NIH Office of Financial Management. She previously served at the Veterans Health Administration and a veteran’s non-profit. In 2021, she received an Honor Award from the NIH Office of the Director.

# data[].attributes.body.value
Ms. Rucker has over 20 years of experience in intellectual property related matters. Ms. Rucker has worked at the NIH OTT since November of 1991, first as a Patent Advisor and then as a Technology Licensing Specialist (TLS), assuming her position as Senior TLS in September 2005. Prior to joining the Office of Technology Transfer was an examiner at the USPTO for 5 ½ years and was awarded partial signatory authority. Ms. Rucker received her J.D. from the Columbus School of Law at the Catholic University of America (May 1992). Ms Rucker is a member of the Maryland Bar (Dec. 1992). She is registered to practice before the USPTO (April 1992). Ms. Rucker has a B.S. in Chemical Engineering and a BS in Microbiology from the University of Maryland College Park.

# data[].attributes.body.processed
Ms. Rucker has over 20 years of experience in intellectual property related matters. Ms. Rucker has worked at the NIH OTT since November of 1991, first as a Patent Advisor and then as a Technology Licensing Specialist (TLS), assuming her position as Senior TLS in September 2005. Prior to joining the Office of Technology Transfer was an examiner at the USPTO for 5 ½ years and was awarded partial signatory authority. Ms. Rucker received her J.D. from the Columbus School of Law at the Catholic University of America (May 1992). Ms Rucker is a member of the Maryland Bar (Dec. 1992). She is registered to practice before the USPTO (April 1992). Ms. Rucker has a B.S. in Chemical Engineering and a BS in Microbiology from the University of Maryland College Park.

# data[].attributes.body.value
Prior to joining the NIH, Fatima Sayyid was with the International Center for Health Outcomes and Innovations Research at the Columbia University Medical Center. Before attaining her multidisciplinary graduate degree, Ms. Sayyid was with the Reproductive Sciences Program, a division of the Department of Obstetrics and Gynecology of the University of Michigan Health System. Ms. Sayyid has a Masters in Health Policy and Management from Columbia University and a Bachelors degree in Biology from the University of Michigan-Flint.

# data[].attributes.body.processed
Prior to joining the NIH, Fatima Sayyid was with the International Center for Health Outcomes and Innovations Research at the Columbia University Medical Center. Before attaining her multidisciplinary graduate degree, Ms. Sayyid was with the Reproductive Sciences Program, a division of the Department of Obstetrics and Gynecology of the University of Michigan Health System. Ms. Sayyid has a Masters in Health Policy and Management from Columbia University and a Bachelors degree in Biology from the University of Michigan-Flint.

# data[].attributes.body.value
Michael joined the OTT in 2003. Prior to joining NIH OTT, Michael practiced law at a Washington, DC law firm’s patent division. Before attending law school, he was a biologist at NINDS and NIMH working in the area of clinical genetics. Michael received a degree in law (J.D.) from American University, Washington College of Law, a B.S. in molecular biology and genetics from the University of Michigan, Ann Arbor, and is continuing his scientific education with graduate level immunology courses at the Foundation for the Advanced Education in the Sciences. Michael is licensed to practice law in the District of Columbia and before the U.S. Patent and Trademark Office.

# data[].attributes.body.processed
Michael joined the OTT in 2003. Prior to joining NIH OTT, Michael practiced law at a Washington, DC law firm’s patent division. Before attending law school, he was a biologist at NINDS and NIMH working in the area of clinical genetics. Michael received a degree in law (J.D.) from American University, Washington College of Law, a B.S. in molecular biology and genetics from the University of Michigan, Ann Arbor, and is continuing his scientific education with graduate level immunology courses at the Foundation for the Advanced Education in the Sciences. Michael is licensed to practice law in the District of Columbia and before the U.S. Patent and Trademark Office.

# data[].attributes.field_job_title
Sr Licensing & Patenting Manager (NHLBI)

# data[].attributes.body.value
Mr. Soukas joined the OTT in 1998. He is a member of the District of Columbia Bar and the American Intellectual Property Law Association and is a 1998 graduate of Franklin Pierce Law Center.

# data[].attributes.body.processed
Mr. Soukas joined the OTT in 1998. He is a member of the District of Columbia Bar and the American Intellectual Property Law Association and is a 1998 graduate of Franklin Pierce Law Center.

# data[].attributes.field_job_title
Sr Licensing & Patenting Manager (NIAID)

# data[].attributes.body.value
Prior to joining TTIPO in 2015 Karen worked as a licensing and patenting manager as part of the CDC Unit at the NIH Office of Technology Transfer (OTT).  After completing her J.D. she worked as a technology transfer specialist at the National Cancer Institute (NCI) Technology Transfer Center (TTC) (Frederick Unit) as a Cancer Research Training Award (CRTA) fellow and also completed her M.B.A.  While completing her J.D. she worked at an academic technology transfer office.    Prior to that Karen completed her B.S. in Cell Molecular Biology and Genetics at the University of Maryland, College Park and then worked in a protein biochemistry lab.

# data[].attributes.body.processed
Prior to joining TTIPO in 2015 Karen worked as a licensing and patenting manager as part of the CDC Unit at the NIH Office of Technology Transfer (OTT).  After completing her J.D. she worked as a technology transfer specialist at the National Cancer Institute (NCI) Technology Transfer Center (TTC) (Frederick Unit) as a Cancer Research Training Award (CRTA) fellow and also completed her M.B.A.  While completing her J.D. she worked at an academic technology transfer office.    Prior to that Karen completed her B.S. in Cell Molecular Biology and Genetics at the University of Maryland, College Park and then worked in a protein biochemistry lab.

# data[].attributes.field_job_title
CDC Team Licensing and Patenting Manager (NIAID)

# data[].attributes.body.value
Dr. Thalhammer-Reyero joined the OTT in 2001. Prior to joining NIH, she was the founder and president of a start-up company, where she developed and patented inventions in the area of computational biology. In earlier years, Dr. Thalhammer-Reyero held various faculty and academic research positions in the areas of immunology, cell biology, cancer biology and biochemistry at Northeastern University, the University of Heidelberg in Germany, Yale University and the University of Vienna in Austria. Dr. Thalhammer-Reyero has a number of publications in peer-reviewed scientific journals and made numerous public presentations related to scientific, business and technology transfer matters. Prior to OTT, she developed and presented business plans to venture capital firms and negotiated various joint-venture and licensing agreements with pharmaceutical, biotech and software companies. She received an M.B.A. in International Business and Finance from the F.W. Olin Graduate School of Business, a Ph.D. in Biochemistry from the University of Vienna in Austria, and Sc.D., M.S. and B.S. degrees in Biology from the Universidad Complutense in Madrid, Spain.

# data[].attributes.body.processed
Dr. Thalhammer-Reyero joined the OTT in 2001. Prior to joining NIH, she was the founder and president of a start-up company, where she developed and patented inventions in the area of computational biology. In earlier years, Dr. Thalhammer-Reyero held various faculty and academic research positions in the areas of immunology, cell biology, cancer biology and biochemistry at Northeastern University, the University of Heidelberg in Germany, Yale University and the University of Vienna in Austria. Dr. Thalhammer-Reyero has a number of publications in peer-reviewed scientific journals and made numerous public presentations related to scientific, business and technology transfer matters. Prior to OTT, she developed and presented business plans to venture capital firms and negotiated various joint-venture and licensing agreements with pharmaceutical, biotech and software companies. She received an M.B.A. in International Business and Finance from the F.W. Olin Graduate School of Business, a Ph.D. in Biochemistry from the University of Vienna in Austria, and Sc.D., M.S. and B.S. degrees in Biology from the Universidad Complutense in Madrid, Spain.

# data[].attributes.field_job_title
Sr Licensing & Patenting Manager (NHLBI)

# data[].attributes.body.value
Dr. Tong obtained her Ph.D. in Molecular Biology from the University of Pennsylvania and studied transcription regulation during cell cycle and myeloid cell differentiation for her thesis. After completion of her graduate studies, she received a National Research Service Award and conducted postdoctoral research at Harvard Medical School and MIT. Dr. Tong also had several years of working experience in biotech industry and is registered to practice before the U.S. Patent and Trademark Office. She was a Technology Transfer Specialist at the Technology Transfer Center of the National Cancer Institute for three years before joining OTT.

# data[].attributes.body.processed
Dr. Tong obtained her Ph.D. in Molecular Biology from the University of Pennsylvania and studied transcription regulation during cell cycle and myeloid cell differentiation for her thesis. After completion of her graduate studies, she received a National Research Service Award and conducted postdoctoral research at Harvard Medical School and MIT. Dr. Tong also had several years of working experience in biotech industry and is registered to practice before the U.S. Patent and Trademark Office. She was a Technology Transfer Specialist at the Technology Transfer Center of the National Cancer Institute for three years before joining OTT.

# data[].attributes.field_job_title
Sr Licensing & Patenting Manager (NIDDK, NIAAA)

# data[].attributes.body.value
Dr. Vathyam returned to the OTT in 2007, having been an intern with OTT earlier in her career. Previously, at the USPTO she examined inventions relating to electrochemistry including biosensors, electrophoresis and microfluidics. For several years, she was the Director of Research and Development at a biotech company where she negotiated contracts and licenses, while developing medical diagnostics and therapeutics. She earned her Ph.D. from The Johns Hopkins University in Biochemistry, where she performed NMR studies on iron containing superoxide dismutase. She received her M.Sc. in Chemistry from the Indian Institute of Technology, Madras, India and B.Sc. in Chemistry from Stella Maris College, Madras, India.

# data[].attributes.body.processed
Dr. Vathyam returned to the OTT in 2007, having been an intern with OTT earlier in her career. Previously, at the USPTO she examined inventions relating to electrochemistry including biosensors, electrophoresis and microfluidics. For several years, she was the Director of Research and Development at a biotech company where she negotiated contracts and licenses, while developing medical diagnostics and therapeutics. She earned her Ph.D. from The Johns Hopkins University in Biochemistry, where she performed NMR studies on iron containing superoxide dismutase. She received her M.Sc. in Chemistry from the Indian Institute of Technology, Madras, India and B.Sc. in Chemistry from Stella Maris College, Madras, India.

# data[].attributes.field_job_title
Sr. Licensing & Patenting Manger (NCATS)

# data[].attributes.body.value
Amanda Wingo has been a Lead IT Project Manager in the Office of Technology Transfer (OTT) since 2020. Previously she served as the Team Lead for the External and Reporting Solutions Business Team at Office of Extramural Research from 2017 to 2020, her first federal position.  Ms. Wingo also worked as a Senior Project Manager for a variety of projects where she lead in the implementation of the Agile framework in the Project Coordination Branch in Electronic Research Administration (eRA) at ORIS/OER/OD from 2009 to 2017. Prior to her work at NIH, she was a Program Director on large IT services contracts at DISA, DOT, and NASA - in each supervising large teams and managing multiple projects across the full software development life cycle. She holds certifications as PMP, ScrumMaster, and in ITIL. Attention to process improvement, customer experience, and enhanced communication have been areas of consistent personal focus, in roles not only as Project/Program Manager but also Business/Systems Analyst, Risk Manager, and Product Owner.   Ms. Wingo, also serves as a Level II COR on the OTT – Technology Transfer Community Website contract. She holds a B.A. from East Stroudsburg University and M.A. in Geography from the University of Maryland.

# data[].attributes.body.processed
Amanda Wingo has been a Lead IT Project Manager in the Office of Technology Transfer (OTT) since 2020. Previously she served as the Team Lead for the External and Reporting Solutions Business Team at Office of Extramural Research from 2017 to 2020, her first federal position.  Ms. Wingo also worked as a Senior Project Manager for a variety of projects where she lead in the implementation of the Agile framework in the Project Coordination Branch in Electronic Research Administration (eRA) at ORIS/OER/OD from 2009 to 2017. Prior to her work at NIH, she was a Program Director on large IT services contracts at DISA, DOT, and NASA - in each supervising large teams and managing multiple projects across the full software development life cycle. She holds certifications as PMP, ScrumMaster, and in ITIL. Attention to process improvement, customer experience, and enhanced communication have been areas of consistent personal focus, in roles not only as Project/Program Manager but also Business/Systems Analyst, Risk Manager, and Product Owner.   Ms. Wingo, also serves as a Level II COR on the OTT – Technology Transfer Community Website contract. She holds a B.A. from East Stroudsburg University and M.A. in Geography from the University of Maryland.

# data[].attributes.body.value
Warren Leonard, M.D., leads the Laboratory of Molecular Immunology under the National Heart, Lung, Blood Institute (NHLBI). This laboratory focuses on “the biology, signaling, and molecular regulation of a key family of these cytokines, the interleukins, with studies ranging from basic molecular mechanisms to human disease.” His lab cloned the IL-21 receptor and performed ground-breaking work on the IL-21 and the thymic stromal lymphopoietin cytokine systems. Dr. Leonard was inducted as a Fellow of NAI in 2018.

# data[].attributes.body.processed
Warren Leonard, M.D., leads the Laboratory of Molecular Immunology under the National Heart, Lung, Blood Institute (NHLBI). This laboratory focuses on “the biology, signaling, and molecular regulation of a key family of these cytokines, the interleukins, with studies ranging from basic molecular mechanisms to human disease.” His lab cloned the IL-21 receptor and performed ground-breaking work on the IL-21 and the thymic stromal lymphopoietin cytokine systems. Dr. Leonard was inducted as a Fellow of NAI in 2018.

# data[].attributes.body.value
George Pavlakis, M.D., Ph.D., is the head of the Human Retrovirus section of the Vaccine Branch of the National Cancer Institute (NCI). His work focuses on developing and testing vaccines and immunotherapies for AIDS and cancer. The Human Retrovirus Section’s current initiatives center around DNA vaccine development. There are currently multiple technologies in this area available for licensing or collaboration that Dr. Pavlakis invented. Dr. Pavlakis was inducted as a NAI Fellow in 2016.

# data[].attributes.body.processed
George Pavlakis, M.D., Ph.D., is the head of the Human Retrovirus section of the Vaccine Branch of the National Cancer Institute (NCI). His work focuses on developing and testing vaccines and immunotherapies for AIDS and cancer. The Human Retrovirus Section’s current initiatives center around DNA vaccine development. There are currently multiple technologies in this area available for licensing or collaboration that Dr. Pavlakis invented. Dr. Pavlakis was inducted as a NAI Fellow in 2016.